This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Eber, B. Articles by Klein, W. Search for Related Content PubMed PubMed Citation Articles by Eber, B. Articles by Klein, W. Social Bookmarking                         What's this?

Evaluation of the Antihypertensive Effect of Lisinopril Compared with Nifedipine in Patients with Mild to Severe Essential Hypertension

Department of Internal Medicine, Cardiology Division, University of Graz, Graz, Austria

Helmut Brussee

Department of Internal Medicine, Cardiology Division, University of Graz, Graz, Austria

Brigitte Rotman

Department of Internal Medicine, Cardiology Division, University of Graz, Graz, Austria

Rudolf Kramer

General Hospital of Linz, Linz, Austria

Werner Klein

Department of Internal Medicine, Cardiology Division, University of Graz, Graz, Austria

For several reasons, increasing numbers of patients with hypertension are treated with angiotensin-converting enzyme inhibitors and calcium channel block ers. In a twenty-four week, double-blind, randomized, parallel study, the anti hypertensive effect of lisinopril (20 to 80 mg qd) and nifedipine (20 to 80 mg bid) were compared in 21 patients. Fourteen patients received lisinopril (mean dose 35 mg), and 7 patients received nifedipine (mean dose 54 mg). By the end of week 12, 8 patients had responded (supine diastolic pressure 90 mg) to lisinopril and 5 to nifedipine. At the end of the study supine systolic/diastolic blood pressure was reduced from 172/104 to 149/92 mmHg with lisinopril and from 171/102 to 158/94 mmHg with nifedipine. No significant difference be tween the two treatments was detected. Three patients were reported to have at least one clinical adverse experience during the active treatment period, 1 in the lisinopril group and 2 in the nifedipine group. No serious clinical adverse experiences were recorded.

In conclusion, lisinopril and nifedipine are both effective in reducing blood pressure in patients with mild to severe hypertension. Lisinopril qd and nifedi pine slow release bid produce similar decreases in blood pressure after twelve weeks of therapy and the safety profiles of the two drugs are similar.

Angiology, Vol. 43, No. 6, 482-489 (1992)
DOI: 10.1177/000331979204300605


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. K. Jacobsen Review: Preventing End-Stage Renal Disease in Diabetic Patients -- Dual Blockade of the Renin-Angiotensin System (Part II) Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 55 - 68. [Abstract] [PDF]